PRISM BioLab Co.,LTD (206A.T)

JPY 292.0

(-1.68%)

Gross Profit Summary of PRISM BioLab Co.,LTD

  • PRISM BioLab Co.,LTD's latest annual gross profit in 2023 was 80.3 Million JPY , down -84.99% from previous year.
  • PRISM BioLab Co.,LTD's latest quarterly gross profit in 2024 Q3 was 57.87 Million JPY , down 0.0% from previous quarter.
  • PRISM BioLab Co.,LTD reported a annual gross profit of 535.13 Million JPY in annual gross profit 2022, down 0.0% from previous year.
  • PRISM BioLab Co.,LTD reported a quarterly gross profit of 80.3 Million JPY for 2023 FY, down -84.99% from previous quarter.
  • PRISM BioLab Co.,LTD reported a quarterly gross profit of 535.13 Million JPY for 2022 FY, down 0.0% from previous quarter.

Annual Gross Profit Chart of PRISM BioLab Co.,LTD (2023 - 2022)

Historical Annual Gross Profit of PRISM BioLab Co.,LTD (2023 - 2022)

Year Gross Profit Gross Profit Growth
2023 80.3 Million JPY -84.99%
2022 535.13 Million JPY 0.0%

Peer Gross Profit Comparison of PRISM BioLab Co.,LTD

Name Gross Profit Gross Profit Difference
KOHJIN BIO CO LTD 1.88 Billion JPY 95.731%
GNI Group Ltd. 22.43 Billion JPY 99.642%
Linical Co., Ltd. 3.77 Billion JPY 97.875%
Trans Genic Inc. 2.24 Billion JPY 96.43%
MEDINET Co., Ltd. 98.25 Million JPY 18.265%
Soiken Holdings Inc. 2.48 Billion JPY 96.765%
Cytori Cell Research Institute, Inc. 1.29 Billion JPY 93.787%
AnGes, Inc. -3.06 Billion JPY 102.62%
OncoTherapy Science, Inc. -177.71 Million JPY 145.187%
Nxera Pharma Co., Ltd. 9.66 Billion JPY 99.169%
Immuno-Biological Laboratories Co., Ltd. 517.29 Million JPY 84.476%
NanoCarrier Co., Ltd. 110.95 Million JPY 27.624%
Carna Biosciences, Inc. 1.45 Billion JPY 94.464%
CanBas Co., Ltd. -984 Million JPY 108.161%
D. Western Therapeutics Institute, Inc. 391.69 Million JPY 79.498%
RaQualia Pharma Inc. 1.65 Billion JPY 95.151%
Chiome Bioscience Inc. 398.59 Million JPY 79.853%
Kidswell Bio Corporation 1.03 Billion JPY 92.274%
PeptiDream Inc. 17.21 Billion JPY 99.534%
Oncolys BioPharma Inc. 30.6 Million JPY -162.395%
Ribomic Inc. -10.5 Million JPY 864.673%
SanBio Company Limited -14.5 Million JPY 653.682%
Healios K.K. 108 Million JPY 25.643%
BrightPath Biotherapeutics Co., Ltd. -341 Thousand JPY 23650.147%
Kubota Pharmaceutical Holdings Co., Ltd. -59.04 Million JPY 236.006%
Delta-Fly Pharma, Inc. -1.51 Million JPY 5411.243%
StemRIM -44.34 Million JPY 281.077%
CellSource Co., Ltd. 3.18 Billion JPY 97.479%
FunPep Company Limited -680.28 Million JPY 111.805%
Kringle Pharma, Inc. 69.25 Million JPY -15.965%
Stella Pharma Corporation 217.29 Million JPY 63.043%
TMS Co., Ltd. -6.95 Million JPY 1255.482%
Noile-Immune Biotech Inc. 314.56 Million JPY 74.47%
Cuorips Inc. 9.63 Million JPY -733.828%
K Pharma,Inc. 910 Million JPY 91.175%
Takara Bio Inc. 25.45 Billion JPY 99.685%
ReproCELL Incorporated 1.1 Billion JPY 92.731%
PhoenixBio Co., Ltd. 1.19 Billion JPY 93.28%
StemCell Institute Inc. 1.57 Billion JPY 94.904%
Japan Tissue Engineering Co., Ltd. 1.66 Billion JPY 95.182%
CellSeed Inc. 107.15 Million JPY 25.056%